Dividend Seeker.
Fund holdings lookup
Request failed

AdvisorShares Psychedelics ETF (PSIL) is an ETF managed by Independent / Boutique. Its largest position is RELMADA THERAPEUTICS, INC. (RLMD), representing 10.17% of fund assets.

AdvisorShares Psychedelics ETF Portfolio Holdings

Source: SEC Form N-PORT institutional portfolio disclosures

Ticker:
PSIL
Type:
ETF
Manager:
Independent / Boutique
Total Assets:
—
Report Date:
Mar 31, 2026
Filing Date:
May 21, 2026
Showing 29 out of 29 holdings
Holding Weight Market Value Shares
-
RELMADA THERAPEUTICS, INC.
10.17% $2,059,269.12 295,872
-
ATAIBECKLEY INC
9.92% $2,009,257.98 567,587
-
Definium Therapeutics, Inc.
8.52% $1,725,588.90 91,301
-
DREY INST PREF GOV MM-M
7.89% $1,598,202.21 1,598,202
-
COMPASS Pathways plc
6.74% $1,364,466.67 246,739
-
NEUROCRINE BIOSCIENCES INC
4.66% $944,575.80 7,170
-
GH Research PLC
4.65% $942,498.04 67,034
-
CYBIN INC.
4.64% $938,899.20 195,604
-
Alkermes plc.
4.60% $932,407.84 26,369
-
JOHNSON & JOHNSON
4.56% $923,494.32 3,778
-
Alto Neuroscience, Inc.
4.55% $922,197.04 41,023
-
BRIGHT MINDS BIOSCIENCES INC.
4.55% $920,370.61 12,613
-
AbbVie Inc.
4.47% $905,845.85 4,165
-
SUPERNUS PHARMACEUTICALS, INC.
4.46% $902,145.57 17,453
-
NRX Pharmaceuticals, Inc.
4.42% $895,594.71 420,467
-
Neuronetics, Inc.
4.42% $894,929.85 617,193
-
BLACKROCK TREASURY TRUST
3.96% $801,415.94 801,416
-
Neuphoria Therapeutics Inc.
3.12% $632,343.69 155,367
-
Quantum Biopharma Ltd.
2.59% $524,494.53 108,591
-
Pasithea Therapeutics Corp.
1.24% $250,363.43 337,508
-
Silo Pharma, Inc.
1.18% $238,828.21 663,965
-
Vistagen Therapeutics, Inc.
0.78% $158,368.37 277,110
-
Incannex Healthcare Inc.
0.36% $73,509.00 24,503
-
NUMINUS WELLNESS INC
0.32% $64,312.96 5,359,413
-
Enveric Biosciences, Inc.
0.16% $32,929.56 16,974
-
Clearmind Medicine Inc.
0.04% $7,651.28 7,357
-
Quantum Biopharma Ltd.
0.00% $0.00 46,617
-
SAGE THERAPEUTICS INC
0.00% $0.00 89,780
-
UNBUZZD WELLNESS INC
0.00% $0.00 263,236
Advertisement (320x50)